Provectus News Provectus Biopharmaceuticals Re
Post# of 22755
Posted On: 11/05/2015 8:53:59 AM
Provectus News
Provectus Biopharmaceuticals Reports Third Quarter 2015 Financial Results
Thursday November 5, 2015
KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus Biopharmaceuticals, Inc. (NYSE MKT: PVCT, www.pvct.com), a clinical-stage oncology and dermatology biopharmaceutical company ("Provectus" or the "Company"
, today announced its results of operations and financial condition for the third quarter ended September 30, 2015.
Provectus will also hold its quarterly business update conference call at 5 p.m. (EST) today to provide a business update on PV-10 and PH-10 to the investment community and answer questions from investors.
Those who wish to participate in the conference call may telephone 877-407-4019 from the U.S. International callers may telephone 201-689-8337 approximately fifteen minutes before the call. A webcast will also be available at www.pvct.com.
A digital replay will be available by telephone approximately two hours after the completion of the call until January 31, 2016 and may be accessed by dialing 877-660-6853 from the U.S. or 201-612-7415 for international callers, and using the Conference ID #13623105.
Third Quarter Financial Results and Balance Sheet Highlights
The Company's cash and cash equivalents were $18.9 million as of September 30, 2015. This is an increase of $1.5 million from the $17.4 million reported as of December 31, 2014.
Stockholders' equity at September 30, 2015, was $24,529,437. This compares to stockholders' equity at December 31, 2014, of $25,189,876.
For additional information regarding Provectus' results of operations and financial condition for the third quarter ended September 30, 2015, please see Provectus' Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 5, 2015.
The complete press release is available at www.pvct.com/pressrelease.html?article=20151105.1 on the Provectus website.
Provectus Biopharmaceuticals Reports Third Quarter 2015 Financial Results
Thursday November 5, 2015
KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus Biopharmaceuticals, Inc. (NYSE MKT: PVCT, www.pvct.com), a clinical-stage oncology and dermatology biopharmaceutical company ("Provectus" or the "Company"
, today announced its results of operations and financial condition for the third quarter ended September 30, 2015. Provectus will also hold its quarterly business update conference call at 5 p.m. (EST) today to provide a business update on PV-10 and PH-10 to the investment community and answer questions from investors.
Those who wish to participate in the conference call may telephone 877-407-4019 from the U.S. International callers may telephone 201-689-8337 approximately fifteen minutes before the call. A webcast will also be available at www.pvct.com.
A digital replay will be available by telephone approximately two hours after the completion of the call until January 31, 2016 and may be accessed by dialing 877-660-6853 from the U.S. or 201-612-7415 for international callers, and using the Conference ID #13623105.
Third Quarter Financial Results and Balance Sheet Highlights
The Company's cash and cash equivalents were $18.9 million as of September 30, 2015. This is an increase of $1.5 million from the $17.4 million reported as of December 31, 2014.
Stockholders' equity at September 30, 2015, was $24,529,437. This compares to stockholders' equity at December 31, 2014, of $25,189,876.
For additional information regarding Provectus' results of operations and financial condition for the third quarter ended September 30, 2015, please see Provectus' Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 5, 2015.
The complete press release is available at www.pvct.com/pressrelease.html?article=20151105.1 on the Provectus website.
(0)
(0)
I'm in it to win it!
NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.
I was born with it, I'm truly blessed!
Alway's searching for winners'
NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.
I was born with it, I'm truly blessed!
Alway's searching for winners'
Scroll down for more posts ▼